NYSEAMERICAN:APHB Ampliphi Biosciences (APHB) Stock Price, News & Analysis $3.62 -0.02 (-0.55%) As of 09/24/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About Ampliphi Biosciences Stock (NYSEAMERICAN:APHB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ampliphi Biosciences alerts:Sign Up Key Stats Today's Range$3.53▼$3.8350-Day Range$3.62▼$5.8452-Week Range$0.15▼$1.37Volume144,441 shsAverage Volume842,200 shsMarket Capitalization$121.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview AmpliPhi Biosciences Corporation was a biotechnology company focused on developing bacteriophage-based therapeutics. Bacteriophages are viruses that selectively infect and destroy specific bacteria, and the company’s programs were aimed at addressing bacterial infections, including those caused by antibiotic-resistant pathogens. Its development pipeline included AB-SA01, an investigational phage therapy targeting Staphylococcus aureus, and AB-PA01, designed to target Pseudomonas aeruginosa. These programs were being evaluated for potential use in serious and chronic infections, including respiratory infections associated with cystic fibrosis. AmpliPhi operated as a clinical-stage biotechnology company and primarily focused on advancing its phage therapy candidates through research and clinical development rather than marketing approved products. In 2019, the company changed its name to Armata Pharmaceuticals, Inc., reflecting its continued focus on precision phage therapeutics.AI Generated. May Contain Errors. Read More Receive APHB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ampliphi Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APHB Stock News HeadlinesAmpliphi Biosciences (NYSEAMERICAN:APHB) Shares Cross Below Fifty Day Moving Average - Here's WhySeptember 18, 2026 | americanbankingnews.comAsian Pac Holdings Bhd (APHB)September 28, 2024 | investing.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery. | Behind the Markets (Ad)Pacific Biosciences Stock (NASDAQ:PACB), Analyst Ratings, Price Targets, PredictionsOctober 24, 2023 | benzinga.comAkston Biosciences Strengthens Board with Addition of John T. PrestonJanuary 25, 2023 | finance.yahoo.comSelecta Biosciences Stock (NASDAQ:SELB), Quotes and News SummaryJanuary 5, 2023 | benzinga.comAPHB: Case Study on AB-PA01 Presented at ISHLT Annual MeetingOctober 26, 2021 | finance.yahoo.comSee More Headlines APHB Stock Analysis - Frequently Asked Questions How have APHB shares performed this year? Ampliphi Biosciences' stock was trading at $6.58 at the start of the year. Since then, APHB stock has decreased by 45.0% and is now trading at $3.62. How were Ampliphi Biosciences' earnings last quarter? Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) released its earnings results on Monday, March, 25th. The biotechnology company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.07. How do I buy shares of Ampliphi Biosciences? Shares of APHB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ampliphi Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ampliphi Biosciences investors own include Navios Maritime Partners (NMM), Sorrento Therapeutics (SRNE), Actinium Pharmaceuticals (ATNM), Protalix BioTherapeutics (PLX), Athersys (ATHX) and Corbus Pharmaceuticals (CRBP). Company Calendar Last Earnings3/25/2019Today9/25/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNYSEAMERICAN:APHB Previous SymbolAMEX:APHB CIK921114 Webwww.ampliphibio.com Phone+1-804-8272524FaxN/AEmployees30Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares33,469,000Free FloatN/AMarket Cap$121.16 million OptionableNot Optionable BetaN/A 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NYSEAMERICAN:APHB) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampliphi Biosciences Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Ampliphi Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
